Reactive oxygen species (ROS)-based nanomedicine
B Yang, Y Chen, J Shi - Chemical reviews, 2019 - ACS Publications
Reactive oxygen species (ROS) play an essential role in regulating various physiological
functions of living organisms. The intrinsic biochemical properties of ROS, which underlie …
functions of living organisms. The intrinsic biochemical properties of ROS, which underlie …
Reactive oxygen species (ROS)-responsive biomaterials mediate tissue microenvironments and tissue regeneration
Y Yao, H Zhang, Z Wang, J Ding, S Wang… - Journal of Materials …, 2019 - pubs.rsc.org
Reactive oxygen species (ROS) have been considered the pivotal signaling molecules in
many physiological processes, and are usually overproduced in various inflammatory …
many physiological processes, and are usually overproduced in various inflammatory …
Bioresponsive drug delivery systems for the treatment of inflammatory diseases
Y Dou, C Li, L Li, J Guo, J Zhang - Journal of Controlled Release, 2020 - Elsevier
Inflammation is intimately related to the pathogenesis of numerous acute and chronic
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …
Engineering cell membrane‐based nanotherapeutics to target inflammation
Inflammation is ubiquitous in the body, triggering desirable immune response to defend
against dangerous signals or instigating undesirable damage to cells and tissues to cause …
against dangerous signals or instigating undesirable damage to cells and tissues to cause …
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Aging-induced alternations of vasculature structures, phenotypes, and functions are key in
the occurrence and development of vascular aging-related diseases. Multiple molecular and …
the occurrence and development of vascular aging-related diseases. Multiple molecular and …
Nanotechnology for cardiovascular diseases
Q Hu, Z Fang, J Ge, H Li - The Innovation, 2022 - cell.com
Cardiovascular diseases have become the major killers in today's world, among which
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …
A proresolving peptide nanotherapy for site‐specific treatment of inflammatory bowel disease by regulating proinflammatory microenvironment and gut microbiota
C Li, Y Zhao, J Cheng, J Guo, Q Zhang… - Advanced …, 2019 - Wiley Online Library
The incidence and prevalence of inflammatory bowel disease (IBD) increases steadily
worldwide. There is an urgent need for effective and safe IBD therapies. Accelerated …
worldwide. There is an urgent need for effective and safe IBD therapies. Accelerated …
Applications of nanobiomaterials in the therapy and imaging of acute liver failure
Highlights This review focuses on the therapeutic mechanisms, targeting strategies of
various nanomaterials in acute liver failure, and recent advances of diverse nanomaterials …
various nanomaterials in acute liver failure, and recent advances of diverse nanomaterials …
Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury
L Li, Y Wang, R Guo, S Li, J Ni, S Gao, X Gao… - Journal of Controlled …, 2020 - Elsevier
Myocardial ischemia-reperfusion injury (MIRI) is a serious threat to the health and lives of
patients without any effective therapy. Excessive production of reactive oxygen species …
patients without any effective therapy. Excessive production of reactive oxygen species …
Site‐specific microRNA‐33 antagonism by pH‐responsive nanotherapies for treatment of atherosclerosis via regulating cholesterol efflux and adaptive immunity
C Li, Y Dou, Y Chen, Y Qi, L Li, S Han… - Advanced functional …, 2020 - Wiley Online Library
Atherosclerosis remains the leading cause of a broad spectrum of deadliest cardiovascular
diseases. MicroRNA‐33 is a new therapeutic target for atherosclerosis due to its diverse …
diseases. MicroRNA‐33 is a new therapeutic target for atherosclerosis due to its diverse …